The bosentan dual endothelin receptor antagonist partly reversed Cx43 remodeling in the PAH hypertrophied right ventricle [130], and combined sildenafil and beraprost inhibited PAH arrhythmogenesis. Here, GJA1 is linked to pulmonary arterial hypertension.